FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

421637006: Lyophilized powder for conventional release solution for injection (dose form)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jan 2024. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3636025015 Lyophilized powder for conventional release solution for injection (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3636026019 Lyophilised powder for conventional release solution for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3636027011 Lyophilized powder for conventional release solution for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3636028018 Lyophilized powder for solution for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3636029014 Lyophilised powder for solution for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Lyophilized powder for conventional release solution for injection Is a Powder for solution for injection false Inferred relationship Some
    Lyophilized powder for conventional release solution for injection Has dose form administration method (attribute) Inject (administration method) false Inferred relationship Some
    Lyophilized powder for conventional release solution for injection Has dose form transformation (attribute) Dissolve (transformation) false Inferred relationship Some
    Lyophilized powder for conventional release solution for injection Has dose form intended site (attribute) Parenteral (intended site) false Inferred relationship Some
    Lyophilized powder for conventional release solution for injection Has dose form release characteristic (attribute) Conventional release (release characteristic) false Inferred relationship Some
    Lyophilized powder for conventional release solution for injection Is a Parenteral dose form (dose form) false Inferred relationship Some
    Lyophilized powder for conventional release solution for injection Has basic dose form (attribute) Lyophilized powder false Inferred relationship Some
    Lyophilized powder for conventional release solution for injection Is a Lyophilized powder for conventional release solution for infusion and/or injection false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Clostridium histolyticum collagenase 900 microgram powder for solution for injection vial Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Velaglucerase alfa 200unit lyophilized powder for injection solution Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely tesamorelin (as tesamorelin acetate) 1 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely belimumab 400 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely belimumab 120 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Canakinumab 150mg powder for injection solution Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely nonacog alfa 1000 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely nonacog alfa 500 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely human immunoglobulin G 6 gram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely mitomycin 40 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely mitomycin 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely octocog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely octocog alfa 500 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely teduglutide 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely onabotulinumtoxinA 200 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely onabotulinumtoxinA 100 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely canakinumab 150 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely lurbinectedin 4 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely azacitidine 100 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely remimazolam (as remimazolam besylate) 20 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely Clostridium histolyticum collagenase 900 microgram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some
    Product containing precisely trilaciclib (as trilaciclib dihydrochloride) 300 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has manufactured dose form False Lyophilized powder for conventional release solution for injection Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start